Rochelle Hines

Associate Professor, Department of Psychology
Expertise: Neurodevelopmental disorders, Autism spectrum disorders, Schizophrenia, Epilepsy, Pharmacology, Molecular genetics, Biochemistry

Biography

Rochelle Hines is an assistant professor of neuroscience in UNLV's psychology department. Her research focuses on improving understanding of neurodevelopmental disorders and promoting novel therapeutic strategies.

For example, Hines' research has examined normal and abnormal brain function in conditions such as autism spectrum disorders, schizophrenia, and developmental epilepsies. She is particularly interested in understanding how various processes during brain development impact signaling and circuitry between cells, as well as behavior. She is a co-director of the Hines Group Comprehensive Neuroscience Lab, which recently delved into the possible medical benefits of psychedelics and other psychoactive compounds.

In addition to research and teaching, Hines mentors and oversees research by high school, undergraduate, graduate, and postdoctoral students. In 2021, her lab received funding from the National Institutes of Health for an initiative to improve collaborative biomedical research efforts in the American West, as well as from the National Institutes of Neurological Disorders and Stroke to further research in that field.

 

Education

  • CIHR Postdoctoral Fellowship, Tufts University School of Medicine
  • Ph.D., Neuroscience, University of British Columbia

Rochelle Hines In The News

Las Vegas Review Journal
Researchers at UNLV are trying to determine if a kitchen spice could become a way to treat seizures.
Las Vegas Review Journal
Within the white, clinical walls of a nondescript UNLV lab, a small team of neuroscientists are working on a project with potentially big implications for children suffering from seizures.
Nutrition Insight
Dr. Dustin Hines, professor of neuroscience at University of Nevada, Las Vegas (UNLV), US, and study co-author Rochelle Hines, professor of psychology, discuss a breakthrough in seizure therapy using compounds derived from caraway seeds. By altering the shape of the seed’s main chemical component, researchers created a new class of THC-free “CBD-like” therapies that showed seizure-reducing effects and promoted healthier brain cell development in preclinical trials, potentially offering safer alternatives to current drug-resistant therapies.
Medical News Today
While many people may consider psychedelics to be solely a recreational drug, research indicates that this drug class can be helpful in treating mental health issues such as depression and addiction.

Articles Featuring Rochelle Hines

Fall colors 2025
Campus News | November 10, 2025

Some of the biggest news headlines featuring UNLV faculty and students.